Skip to main content
Subjects

Pharma

16 July 2024

The forthcoming U.S. BIOSECURE Act is already making an impact on the China business strategy of global pharmaceutical companies. What are the implications for your China risk exposure?

Blog
Biopharmaceutical companies worldwide have expressed their intentions to continue investing in China. However, the forthcoming U.S. BIOSECURE Act means that many are proactively reassessing their China business strategies. Pamir has been working with pharma

Resource Library

Visit our Resources hub

04 November 2024

New PRC Cyber Data Security Regulations Will Impact U.S. Sensitive Data in China

Blog
On 24 September, the State Council of the People’s Republic of China (PRC) issued the order to promulgate the “Regulations on the Management of Network Data Security” (网络数据安全管理条例), hereafter referred to as Cyber Data Security Regulations).
01 November 2024

China and Vietnam Play Down Disputes in the South China Sea

Blog
On 29 September, a Vietnamese fishing boat clashed with Chinese maritime law enforcement ships in the disputed waters around the Paracel Islands in the South China Sea (SCS).
17 October 2024

Beijing’s Pursuit of Green Economy Will Strain China’s Foreign Relations

Blog
On 11 August, the Chinese government issued the “Opinions of the CCP Central Committee and the State Council on Expediting Comprehensive Green Transformation for Economic and Social Development” (中共中央 国务院关于加快经济社会发展全面绿色转型的意见).
Make contact with Pamir

Ready to get started on your
China strategy?

Get in touch with us

Contact Pamir